Tuesday, Nov. 17, 2026 · about a 5-minute read
Good morning. Yesterday a Toyota with no one at the wheel started picking up paying riders around the clock in Guangzhou, Europe's regulators backed a once-a-week growth shot for children with dwarfism, scientists grew tiny human eye lenses in a dish to hunt for cataract drugs, and a plant compound joined the fight against aging's zombie cells. Today, the forecasters who now expect an AI that out-researches its makers by 2027.
The big one
Science on Fast-Forward? Forecasters Now Expect an AI That Out-Researches Its Makers by 2027 The AI Futures Project, the team behind the "AI 2027" scenario, now puts its central guesses for a Superhuman AI Researcher, an AI that does AI research better than the best humans, between May and August 2027. What moved them was an estimate from METR, an outside group that evaluates AI systems, that one leading lab's research is running at about twice its historical pace, mostly because of AI itself. It is one group's forecast, and the forecasters say METR redacted most of the evidence behind it.
Why it matters: research on drugs, materials and aging runs through researchers' time, and an AI that speeds up research itself would speed up all of it. Our odds on when an AI out-researches the best humans are below the line. Read it →
Yesterday on the site
The End of Aging
Aging's Zombie Cells Meet a Second Foe: A Plant Compound Lengthened Life in Mice: cepharanthine, an alkaloid from Stephania plants long used as a drug in parts of Asia, cleared senescent cells and lengthened life in worms, zebrafish and two kinds of mice (in animals; secondary report, lifespan figures not yet confirmed).
The End of Disease
Cataracts Without Surgery? Scientists Grew Tiny Human Eye Lenses in a Dish to Test Drugs: a UK-Japan team grew the first human eye-lens "mini organs" from reprogrammed adult cells, giving drug hunters human lens tissue on demand to test cataract medicines (lab-dish work; university release).
One Growth Shot a Week, Not Seven: Europe Backs It for Children With Dwarfism: Europe's medicines committee backed navepegritide, a once-weekly shot, for children 2 and older with achondroplasia; its maker expects the final decision by year-end and a first launch in Germany in early 2027 (company statement).
Superhuman
Rebuilding the Eye's Light Sensors Restored Sight in Rodents, Its Maker Says: Mogrify says a virus carrying master genes turned the retina's support cells into light-catching photoreceptors and restored visual function in rodents, with full data due Dec. 3 (in rodents; company claim).
Robots & Self-Driving
A Toyota With No One at the Wheel Now Picks Up Riders at 3 A.M. in Guangzhou: Pony.ai and Toyota say their factory-built bZ4X robotaxi now carries paying riders in Guangzhou 24 hours a day with no safety driver, about nine months after the first one came off the line (company claim).
To the Stars
The Race to Replace the Space Station Is Down to Three as Blue Origin Bows Out: Blue Origin told staff it will skip NASA's next private-station round to focus on the Moon, leaving Starlab, Axiom and Vast as the likely bidders, with Vast building a station to launch in early 2027 (secondary report).
Sci-Fi Tech
Siri Could Soon See What People See: Apple's First Glasses Are Reportedly Due in 2027: Apple's first smart glasses reportedly have no screen, let Siri answer questions about whatever the cameras see, and aim for a June 2027 reveal and a late-2027 sale (secondary report of Bloomberg's Mark Gurman; Apple has confirmed nothing).
Poland's Fast-Train Future Goes Underground: A 430-Ton Drill Head Just Dropped Into Łódź: a 430-ton cutterhead is in the launch shaft for a 4.6-kilometer high-speed rail tunnel under Łódź, with full digging now set for spring 2027 (secondary report).
By the numbers
52 instead of 365: injections a year for a child on the weekly growth shot instead of the daily one.
94 million: people worldwide estimated to have cataracts, whose only treatment today is surgery.
430 tons: the cutterhead lowered into Łódź, the front end of a tunnel machine about 130 meters long.
24 hours: how much of each day the driverless Toyota robotaxis now carry paying riders in Guangzhou.
New on the odds board
Yesterday's posts put fresh odds on Pony.ai and Toyota running about 1,000 bZ4X robotaxis in China, Europe approving the weekly growth shot, a human trial testing cepharanthine as a zombie-cell drug, a person being dosed with a retina-rebuilding cell-conversion therapy, Apple's first smart glasses going on sale, a NASA-backed private station running in orbit, high-speed trains linking Łódź, Warsaw and Poland's new airport, and a cataract drug first tested on mini lenses entering human trials. The whole board lives on the calculator.
On the calendar
Nov. 18: China's license rule for exporting tunnel-boring machines takes effect.
Dec. 3: Mogrify presents its rodent sight-restoring data, the first look at how big the effect was and how long it lasted.
By Dec. 31: the European Commission's final decision on the weekly growth shot for achondroplasia.
First quarter of 2027: the planned first European launch of the weekly shot, in Germany, if authorized.
Feb. 4, 2027: the FDA's target date for BridgeBio's oral infigratinib, a growth pill for children with achondroplasia.
Spring 2027: continuous digging begins under Łódź, heading for Fabryczna station.
The story we're following
Digital patients: stand-ins for real people that could shorten the wait for nearly every new medicine. Yesterday's step was a physical one. A team from Anglia Ruskin, Osaka and Cardiff universities grew the first human eye-lens mini organs from reprogrammed adult cells, so cataract-drug hunters no longer have to wait on scarce human lens tissue. The step the team names next: testing new medicines on them. Read it →
Quote of the day
"When a distinguished but elderly scientist states that something is possible, he is almost certainly right. When he states that something is impossible, he is very probably wrong." — Arthur C. Clarke, the science-fiction writer and futurist, in his 1962 book Profiles of the Future (chapter "Hazards of Prophecy: The Failure of Imagination"), as traced by Quote Investigator. His example was the physicist Ernest Rutherford, who called power from the atom "moonshine" in 1933. This week's forecasters are betting the other way, on AI that speeds up science itself.
Coming up
Already up this morning: forecasters now expect an AI that out-researches its makers by 2027. Later today: at 9 AM, rockets could carry their own AI data centers into orbit as an Indian launch startup signs a factory deal.
Until next time
That's today in the future. If someone you know would want to wake up to this, forward it to them, and if you're reading a forward, subscribe here. It's free every morning.



